Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial

Alexander C. Ford, Damien Hindmarch, Sarah Alderson et al.|The Lancet|2023

Cited by 138